Cagrilintide

Description

Cagrilintide is a synthetic peptide that acts as a selective glucagon-like peptide-1 (GLP-1) receptor agonist. It has garnered significant attention in research for its potential in regulating appetite, enhancing fat metabolism, and supporting weight loss. Cagrilintide is primarily used in studies related to obesity, metabolic syndrome, and insulin sensitivity, offering insights into the hormonal regulation of energy balance and food intake.

By activating the GLP-1 receptor, Cagrilintide helps to increase satiety, slow gastric emptying, and reduce appetite, which contributes to a decrease in overall food consumption. It also plays a role in improving insulin sensitivity, making it an essential tool in the study of metabolic diseases such as type 2 diabetes and obesity. Researchers are investigating its potential to improve weight management and its effects on fat mass, muscle preservation, and energy expenditure in both clinical and pre-clinical settings.

The 10mg vial of Cagrilintide is ideal for researchers starting studies on metabolic health, appetite regulation, and the treatment of obesity. This vial size is suitable for in vitro studies, receptor binding assays, and initial in vivo experiments in animal models, providing enough material for focused research without requiring larger quantities.

Progression Peptides offers Cagrilintide as a high-purity lyophilized powder with third-party purity verification to ensure the peptide meets rigorous research standards. The lyophilized form preserves the peptide’s stability and bioactivity when stored and handled according to recommended guidelines.

Reconstitution: Reconstitute with bacteriostatic water, allowing it to dissolve gently without agitation. The solution should remain clear and free from visible particles.

Storage: Store the lyophilized peptide at -20°C. Once reconstituted, refrigerate at 2-8°C and use within 30 days.

For research purposes only. Not for human consumption or veterinary use. Sold exclusively for laboratory and in vitro research.